Exercise-related hypoglycemia in diabetes mellitus

Expert Review of Endocrinology and Metabolism

Volumn 6, Issue 1, 2011, Pages 93-108

  Younk, Lisa M ^a   Mikeladze, Maia ^a   Tate, Donna ^a   Davis, Stephen N ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

exercise; hypoglycemia; hypoglycemia associated autonomic failure; insulin; insulin secretagogues; physical activity; Type 1 diabetes mellitus; Type 2 diabetes mellitus

Indexed keywords

CARBOHYDRATE; FATTY ACID; GLUCOSE; INSULIN; INSULIN ASPART; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN GLULISINE; INSULIN LISPRO; ISOPHANE INSULIN;

AUTONOMIC DYSFUNCTION; AUTONOMIC NERVOUS SYSTEM; BLOOD GLUCOSE MONITORING; CARDIOVASCULAR RISK; ENERGY CONSUMPTION; ENERGY METABOLISM; EXERCISE; EXERCISE INTENSITY; FATTY ACID METABOLISM; GLUCONEOGENESIS; GLUCOSE TRANSPORT; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INSULIN RELEASE; INSULIN TREATMENT; LIPID OXIDATION; NEUROENDOCRINE SYSTEM; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SCREENING; SEX DIFFERENCE;

EID: 78650462580     PISSN: 17446651     EISSN: None     Source Type: Journal    
DOI: 10.1586/eem.10.78     Document Type: Review

References (152)

1. Centers for Disease Control and Prevention (CDC). Prevalence of self-reported physically active adults - United States, 2007. MMWR Morb. Mortal. Wkly Rep. 57(48), 1297-1300 (2008).
2. Reichard P, Nilsson B, Rosenqvist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N. Engl. J. Med. 329(5), 304-309 (1993).
3. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. N. Engl. J. Med. 329(14), 977-986 (1993).
4. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/ EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with Type 1 diabetes. N. Engl. J. Med. 353(25), 2643-2653 (2005).
5. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with Type 2 diabetes (UKPDS 33). Lancet 352(9131), 837-853 (1998).
6. American Diabetes Association. Clinical practice recommendations 1995: position statement: standards of medical care for patients with diabetes mellitus. Diabetes Care 18(Suppl. 1), S8-S15 (1995).
7. Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in Type 2 diabetes. N. Engl. J. Med. 358(24), 2545-2559 (2008).
8. ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with Type 2 diabetes. N. Engl. J. Med. 358(24), 2560-2572 (2008).
9. Miller CD, Phillips LS, Ziemer DC, Gallina DL, Cook CB, El-Kebbi IM. Hypoglycemia in patients with Type 2 diabetes mellitus. Arch. Intern. Med. 161(13), 1653-1659 (2001).
10. Jennings AM, Wilson RM, Ward JD. Symptomatic hypoglycemia in NIDDM patients treated with oral hypoglycemic agents. Diabetes Care 12(3), 203-207 (1989).
11. Diedrich L, Sandoval D, Davis SN. Hypoglycemia associated autonomic failure. Clin. Auton. Res. 12(5), 358-365 (2002).
12. Zammitt NN, Frier BM. Hypoglycemia in Type 2 diabetes: pathophysiology, frequency, and effects of different treatment modalities. Diabetes Care 28(12), 2948-2961 (2005).
13. Donnelly LA, Morris AD, Frier BM et al.; DARTS/MEMO Collaboration. Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: a population-based study. Diabet. Med. 22(6), 749-755 (2005).
14. Henderson JN, Allen KV, Deary IJ, Frier BM. Hypoglycaemia in insulin-treated Type 2 diabetes: frequency, symptoms and impaired awareness. Diabet. Med. 20(12), 1016-1021 (2003).
15. Davis SN, Mann S, Briscoe VJ, Ertl AC, Tate DB. Effects of intensive therapy and antecedent hypoglycemia on counter-regulatory responses to hypoglycemia in Type 2 diabetes. Diabetes 58(3), 701-709 (2009).
16. Segel SA, Paramore DS, Cryer PE. Hypoglycemia-associated autonomic failure in advanced Type 2 diabetes. Diabetes 51(3), 724-733 (2002).
17. Wright RJ, Frier BM. Vascular disease and diabetes: is hypoglycemia an aggravating factor? Diabetes Metab. Res. Rev. 24(5), 353-363 (2008).
18. Wright RJ, Newby DE, Stirling D, Ludlam CA, Macdonald IA, Frier BM. Effects of acute insulin-induced hypoglycemia on indices of inflammation: putative mechanism for aggravating vascular disease in diabetes. Diabetes Care 33(7), 1591-1597 (2010).
19. Joy NG, Hedrington MS, Briscoe VJ, Tate DB, Ertl AC, Davis SN. Effects of acute hypoglycemia on inflammatory and pro-atherothrombotic biomarkers in individuals with Type 1 diabetes and healthy individuals. Diabetes Care 33(7), 1529-1935 (2010).
20. Wild D, von Maltzahn R, Brohan E, Christensen T, Clauson P, Gonder-Frederick L. A critical review of the literature on fear of hypoglycemia in diabetes: implications for diabetes management and patient education. Patient Educ. Couns. 68(1), 10-15 (2007).
21. Diabetes Prevention Program Research Group. Reduction in the incidence of Type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 346(6), 393-403 (2002).
22. The Look AHEAD Research Group. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with Type 2 diabetes mellitus: four-year results of the Look AHEAD trial. Arch. Intern. Med. 170(17), 1566-1575 (2010).
23. Conn VS, Hafdahl AR, LeMaster JW, Ruppar TM, Cochran JE, Nielsen PJ. Meta-analysis of health behavior interventions in Type 1 diabetes. Am. J. Health. Behav. 32(3), 315-329 (2008).
24. Conn VS, Hafdahl AR, Brown LM. Meta-analysis of quality-of-life outcomes from physical activity interventions. Nurs. Res. 58(3), 175-183 (2009).
25. The Diabetes Research in Children Network (DirecNet) Study Group. Impact of exercise on overnight glycemic control in children with Type 1 diabetes mellitus. J. Pediatr. 147(4), 528-534 (2005).
26. Rabasa-Lhoret R, Bourque J, Ducros F, Chiasson J-L. Guidelines for premeal insulin dose reduction for postprandial exercise of different intensities and durations in Type 1 diabetic subjects treated intensively with a basal-bolus insulin regimen (ultralente-lispro). Diabetes Care 24(4), 625-630 (2001).
27. Hernandez JM, Moccia T, Fluckey JD, Ulbrecht JS, Farrell PA. Fluid snacks to help persons with Type 1 diabetes avoid late onset postexercise hypoglycemia. Med. Sci. Sports Exerc. 32(5), 904-910 (2000).
28. Sonnenberg GE, Kemmer FW, Berger M. Exercise in Type 1 (insulin-dependent) diabetic patients treated with continuous subcutaneous insulin infusion: prevention of exercise induced hypoglycaemia. Diabetologia 33(11), 696-703 (1990).
29. MacDonald MJ. Postexercise late-onset hypoglycemia in insulin-dependent diabetic patients. Diabetes Care 10(5), 584-588 (1987).
30. Davis SN, Galassetti P, Wasserman DH, Tate D. Effects of antecedent hypoglycemia on subsequent counter-regulatory responses to exercise. Diabetes 49(1), 73-81 (2000).
31. Galassetti P, Tate D, Neill RA, Morrey S, Wasserman DH, Davis SN. Effect of antecedent hypoglycemia on counter-regulatory responses to subsequent euglycemic exercise in Type 1 diabetes. Diabetes 52(7), 1761-1769 (2003).
32. Galassetti P, Mann S, Tate D et al. Effects of antecedent prolonged exercise on subsequent counter-regulatory responses to hypoglycemia. Am. J. Physiol. Endocrinol. Metab. 280(6), E908-E917 (2001).
33. Galassetti P, Tate D, Neill RA, Richardson A, Leu SY, Davis SN. Effect of differing antecedent hypoglycemia on counter-regulatory responses to exercise in Type 1 diabetes. Am. J. Physiol. Endocrinol. Metab. 290(6), E1109-E1117 (2006).
34. Sandoval DA, Aftab Guy DL, Richardson MA, Ertl AC, Davis SN. Effects of low and moderate antecedent exercise on counter-regulatory responses to subsequent hypoglycemia in Type 1 diabetes. Diabetes 53(7), 1798-1806 (2004).
35. Sandoval DA, Aftab Guy DL, Richardson MA, Ertl AC, Davis SN. Acute, same-day effects of antecedent exercise on counter-regulatory responses to subsequent hypoglycemia in Type 1 diabetes mellitus. Am. J. Physiol. Endocrinol. Metab. 290(6), E1331-E1338 (2006).
36. Brazeau A-S, Rabasa-Lhoret R, Strychar I, Mircescu H. Barriers to physical activity among patients with Type 1 diabetes. Diabetes Care 31(11), 2108-2109 (2008).
37. Exercise and Sport in Diabetes (2nd Edition). Nagi D (Ed.). John Wiley and Sons, Ltd, Chichester, UK (2005).
38. Sigal RJ, Kenny GP, Wasserman DH, Castaneda-Sceppa C. Physical activity/ exercise and Type 2 diabetes. Diabetes Care 27(10), 2518-2539 (2004).
39. Coggan AR. Plasma glucose metabolism during exercise in humans. Sports Med. 11(2), 102-124 (1991).
40. Spriet LL, Watt MJ. Regulatory mechanisms in the interaction between carbohydrate and lipid oxidation during exercise. Acta Physiol. Scand. 178(4), 443-452 (2003).
41. Goldfine AB, Maratos-Flier E. Oral agents for the treatment of Type II diabetes mellitus. In: Principles and Practice of Endocrinology and Metabolism (3rd Edition). Becker K (Ed.). JB Lippincott Company, Philadelphia, PA, USA 1344-1348 (2001).
42. Tentolouris N, Voulgari C, Katsilambros N. A review of repaglinide in the management of patients with Type 2 diabetes. Vasc. Health Risk Manag. 3(6), 797-807 (2007).
43. Barnett AH. Avoiding hypoglycaemia while achieving good glycaemic control in Type 2 diabetes through optimal use of oral agent therapy. Curr. Med. Res. Opin 26(6), 1333-1342 (2010).
44. Gerich JE, Langlois M, Noacco C, Karam JH, Forsham PH. Lack of glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic a cell defect. Science 182(108), 171-173 (1973).
45. Bolli G, deFeo P, Compagnucci P et al. Abnormal glucose counterregulation in insulin dependent diabetes mellitus: interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion. Diabetes 32(2), 134-141 (1983).
46. Meneilly GS, Cheung E, Tuokko H. Counter-regulatory hormone responses to hypoglycemia in the elderly patient with diabetes. Diabetes 43(3), 403-410 (1994).
47. Zander E, Schulz B, Chlup R, Woltansky P, Lubs D. Muscular exercise in Type 1-diabetics. II. Hormonal and metabolic responses to moderate exercise. Exp. Clin. Endocrinol. 85(1), 95-104 (1985).
48. Kang J, Kelley DE, Robertson RJ et al. Substrate utilization and glucose turnover during exercise of varying intensities in individuals with NIDDM. Med. Sci. Sports Exerc. 31(1), 82-89 (1999).
49. de Glisezinski I, Larrouy D, Bajzova M et al. Adrenaline but not noradrenaline is a determinant of exercise-induced lipid mobilization in human subcutaneous tissue. J. Physiol. 587(13), 3393-3404 (2009).
50. Zouhal H, Jacob C, Delamarche P, Gratas-Delamarche A. Catecholamines and the effects of exercise, training and gender. Sports Med. 38(5), 401-423 (2008).
51. Watt MJ, Howlett KF, Febbraio MA, Spriet LL, Hargreaves M. Adrenaline increases skeletal muscle glycogenolysis, pyruvate dehydrogenase activation and carbohydrate oxidation during moderate exercise in humans. J. Physiol. 534(1), 269-278 (2001).
52. Schneider S, Vitug A, Ananthakrishnan R, Khachadurian A. Impaired adrenergic response to prolonged exercise in Type I diabetes. Metabolism 40(11), 1219-1225 (1991).
53. Bottini P, Boschetti E, Pampanelli S et al. Contribution of autonomic neuropathy to reduced plasma adrenaline responses to hypoglycemia in IDDM: evidence for a nonselective defect. Diabetes 46(5), 814-823 (1997).
54. Cryer PE. Iatrogenic hypoglycemia as a cause of hypoglycemia-associated autonomic failure in IDDM. Diabetes 41(3), 255-260 (1992).
55. Amiel SA, Sherwin RS, Simonson DC, Tamborlane WV. Effect of intensive insulin therapy on glycemic thresholds for counter-regulatory hormone release. Diabetes 37(7), 901-907 (1988).
56. Dagogo-Jack SE, Craft S, Cryer PE. Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus: recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia. J. Clin. Invest. 91(3), 819-828 (1993).
57. Fanelli C, Pampanelli S, Epifano L et al. Long-term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypoglycaemia following institution of rational intensive insulin therapy in IDDM. Diabetologia 37(12), 1265-1276 (1994).
58. Hirsch I, Marker J, Smith L et al. Insulin and glucagon in prevention of hypoglycemia during exercise in humans. Am. J. Physiol. Endocrinol. Metab. 260(23), E695-E704 (1991).
59. Zinker B, Mohr T, Kelly P, Namdaran K, Bracy D, Wasserman D. Exercise-induced fall in insulin: mechanism of action at the liver and effects on muscle glucose metabolism. Am. J. Physiol. Endocrinol. Metab. 266(29), E683-E689 (1994).
60. Lavoie C, Ducros F, Bourque J, Langelier H, Chiasson J. Glucose metabolism during exercise in man: the role of insulin and glucagon in the regulation of hepatic glucose production and gluconeogenesis. Can. J. Physiol. Pharmacol. 75(1), 26-35 (1997).
61. Wasserman DH, Spalding JA, Lacy DB, Colburn CA, Goldstein RE, Cherrington AD. Glucagon is a primary controller of hepatic glycogenolysis and gluconeogenesis during muscular work. Am. J. Physiol. Endocrinol. Metab. 257(1), E108-E117 (1989).
62. Petersen K, Price T, Bergeron R. Regulation of net hepatic glycogenolysis and gluconeogenesis during exercise: impact of Type 1 diabetes. J. Clin. Endocrinol. Metab. 89(9), 4656-4664 (2004).
63. Trimmer J, Schwarz J-M, Casazza G, Horning M, Rodriguez N, Brooks G. Measurement of gluconeogenesis in exercising men by mass isotopomer distribution analysis. J. Appl. Physiol. 93(1), 233-241 (2002).
64. Cersosimo E, Garlick P, Ferretti J. Regulation of splanchnic and renal substrate supply by insulin in humans. Metabolism 49(5), 676-683 (2000).
65. Coker R, Koyama Y, Denny J, Camacho R, Lacy D, Wasserman D. Prevention of overt hypoglycemia during exercise: stimulation of endogenous glucose production independent of hepatic catecholamine action and changes in pancreatic hormone concentration. Diabetes 51(5), 1310-1318 (2002).
66. Wasserman D. Four grams of glucose. Am. J. Physiol. Endocrinol. Metab. 296(1), E11-E21 (2009).
67. Shilo S, Sotsky M, Shamoon H. Islet hormonal regulation of glucose turnover during exercise in Type 1 diabetes. J. Clin. Endocrinol. Metab. 70(1), 162-172 (1990).
68. Martin IK, Katz A, Wahren J. Splanchnic and muscle metabolism during exercise in NIDDM patients. Am. J. Physiol. 269(32), E583-E590 (1995).
69. Minuk HL, Vranic M, Marliss EB, Hanna AK, Albisser AM, Zinman B. Glucoregulatory and metabolic response to exercise in obese non-insulin- dependent diabetes. Am. J. Physiol. 240(5), E458-E464 (1981).
70. Larsen JJ, Dela F, Madsbad S, Vibe- Petersen J, Galbo H. Interaction of sulphonylureas and exercise on glucose homeostasis in Type 2 diabetic patients. Diabetes Care 22(10), 1647-1654 (1999).
71. Ahlborg G, Felig P, Hagenfeldt L, Hendler R, Wahren J. Substrate turnover during prolonged exercise in man: splanchnic and leg metabolism of glucose, free fatty acids, and amino acids. J. Clin. Invest. 53(4), 1080-1090 (1974).
72. Kiens B. Skeletal muscle lipid metabolism in exercise and insulin resistance. Physiol. Rev. 86(1), 205-243 (2006).
73. Fernandez C, Hansson O, Nevsten P, Holm C, Klint C. Hormone-sensitive lipase is necessary for normal mobilization of lipids during submaximal exercise. Am. J. Physiol. Endocrinol. Metab. 295(1), E179-E186 (2008).
74. Langin D. Adipose tissue lipolysis as a metabolic pathway to define pharmacological strategies against obesity and the metabolic syndrome. Pharmacol. Res. 53(6), 482-491 (2006).
75. Sengenès C, Bouloumié A, Hauner H et al. Involvement of a cGMP-dependent pathway in the natriuretic peptide-mediated hormone-sensitive lipase phosphorylation in human adipocytes. J. Biol. Chem. 278(49), 48617-48626 (2003).
76. Watt M, Holmes A, Pinnamaneni S et al. Regulation of HSL serine phosphorylation in skeletal muscle and adipose tissue. Am. J. Physiol. Endocrinol. Metab. 290(3), E500-E508 (2006).
77. Wolfe R, Klein S, Carraro F, Weber J. Role of triglyceride-fatty acid cycle in controlling fat metabolism in humans during and after exercise. Am. J. Physiol. Endocrinol. Metab. 258(2), E382-E389 (1990).
78. Chokkalingam K, Tsintzask K, Norton L, Jewell K, Macdonald IA, Mansell PI. Exercise under hyperinsulinemic conditions increases whole-body glucose disposal without affecting muscle glycogen utilization in Type 1 diabetes. Diabetologia 50(2), 414-421 (2007).
79. Jenni S, Oetliker C, Allemann S et al. Fuel metabolism during exercise in euglycaemia and hyperglycaemia in patients with Type 1 diabetes mellitus - a prospective single-blinded randomised crossover trial. Diabetologia 51(8), 1457-1465 (2008).
80. Kelley DE, Mandarino LJ. Fuel selection in human skeletal muscle in insulin resistance: a reexamination. Diabetes 49(5), 677-683 (2000).
81. Jessen N, Goodyear LJ. Contraction signaling to glucose transport in skeletal muscle. J. Appl. Physiol. 99(1), 330-337 (2005).
82. Nesher R, Karl IE, Kipnis DM. Dissociation of effects of insulin and contraction on glucose transport in rat epitrochlearis muscle. Am. J. Physiol. Cell. Physiol. 249(18), C226-C232 (1985).
83. Gao J, Ren J, Gulve EA, Holloszy JO. Additive effect of contractions and insulin on GLUT-4 translocation into the sarcolemma. J. Appl. Physiol. 77(4), 1597-1601 (1994).
84. DeFronzo RA, Ferrannini E, Sato Y, Felig P, Wahren J. Synergistic interaction between exercise and insulin on peripheral glucose uptake. J. Clin. Invest. 68(6), 1468-1474 (1981).
85. Wasserman DH, Geer RJ, Rice DE et al. Interaction of exercise and insulin action in humans. Am. J. Physiol. Endocrinol. Metab. 260(1 Pt 1), E37-E45 (1991).
86. Kennedy JW, Hirshman MF, Gervino EV et al. Acute exercise induces GLUT4 translocation in skeletal muscle of normal human subjects and subjects with Type 2 diabetes. Diabetes 48(5), 1192-1197 (1999).
87. Christ-Roberts CY, Pratipanawatr T, Pratipanawatr W, Berria R, Belfort R, Mandarino LJ. Increased insulin receptor signaling and glycogen synthase activity contribute to the synergistic effect of exercise on insulin action. J. Appl. Physiol. 95(6), 2519-2529 (2003).
88. Galbo H, Tobin L, van Loon LJ. Responses to acute exercise in Type 2 diabetes, with an emphasis on metabolism and interaction with oral hypoglycemic agents and food intake. Appl. Physiol. Nutr. Metab. 32(3), 567-575 (2007).
89. Gaudet-Savard T, Ferland A, Broderick TL et al. Safety and magnitude of changes in blood glucose levels following exercise in the fasted and the postprandial state in men with Type 2 diabetes. Eur. J. Cardiovasc. Prev. Rehabil. 14(6), 831-836 (2007).
90. Pencek RR, James F, Lacy DB et al. Interaction of insulin and prior exercise in control of hepatic metabolism of a glucose load. Diabetes 52(8), 1897-1903 (2003).
91. Pencek RR, James FD, Lacy DB et al. Exercise-induced changes in insulin and glucagon are not required for enhanced hepatic glucose uptake after exercise but influence the fate of glucose within the liver. Diabetes 53(12), 3041-3047 (2004).
92. Mikines KJ, Sonne B, Ferrell PA, Tronier B, Galbo H. Effect of physical exercise on sensitivity and responsiveness to insulin in humans. Am. J. Physiol. Endocrinol. Metab. 254(3), E248-E259 (1988).
93. Annuzzi G, Riccardi G, Capaldo B, Kaijser L. Increased insulin-stimulated glucose uptake by exercised human muscles one day after prolonged physical exercise. Eur. J. Clin. Invest. 21(1), 6-12 (1991).
94. The Diabetes Research in Children Network (DirecNet) Study Group. Prevention of hypoglycemia during exercise in children with Type 1 diabetes by suspending basal insulin. Diabetes Care 29(10), 2200-2204 (2006).
95. Taplin CE, Cobry E, Messer L, McFann K, Chase HP, Faillo-Scharer R. Preventing post-exercise nocturnal hypoglycemia in children with Type 1 diabetes. J. Pediatr. 157(5), 784-788 (2010).
96. Praet SFE, Manders RJF, Lieverse AG et al. Influence of acute exercise on hyperglycemia in insulin-treated Type 2 diabetes. Med. Sci. Sports Exerc. 38(12), 2037-2044 (2006).
97. Davis SN, Shavers C, Costa F. Differential gender responses to hypoglycemia are due to alterations in CNS drive and not glycemic thresholds. Am. J. Physiol. Endocrinol. Metab. 279(5), E1054-E1063 (2000).
98. Davis SN, Shavers C, Mosqueda-Garcia R, Costa F. Effects of differing antecedent hypoglycemia on subsequent counterregulation in normal humans. Diabetes 46(8), 1328-1335 (1997).
99. Davis SN, Tate D. Effects of morning hypoglycemia on neuroendocrine and metabolic responses to subsequent afternoon hypoglycemia in normal man. J. Clin. Endocrinol. Metab. 86(5), 2043-2050 (2001).
100. Cranston I, Lomas J, Maran A, Macdonald I, Amiel SA. Restoration of hyoglycaemia awareness in patients with long-duration insulin-dependent diabetes. Lancet 344(8918), 283-287 (1994).
101. Cryer PE. Mechanisms of hypoglycemia-associated autonomic failure and its component syndromes in diabetes. Diabetes 54(12), 3592-3601 (2005).
102. Diabetes Research in Children Network (DirecNet) Study Group; Tsalikian E, Tamborlane W, Xing D et al. Blunted counter-regulatory responses to hypoglycemia in young children and adolescents with well-controlled Type 1 diabetes. Diabetes Care 32(11), 1954-1959 (2009).
103. Leese GP, Wang J, Broomhall J et al.; The DARTS/MEMO Collaboration. Frequency of severe hypoglycemia requiring emergency treatment in Type 1 and Type 2 diabetes: a population-based study of health service resource use. Diabetes Care 26(4), 1176-1180 (2003).
104. Holstein A, Plaschke A, Egberts EH. Clinical characterization of severe hypoglycaemia - a prospective population-based study. Exp. Clin. Endocrinol. Diabetes 111(6), 364-369 (2003).
105. Matyka K, Evans M, Lomas J, Cranston I, Macdonald I, Amiel SA. Altered hierarchy of protective responses against severe hypoglycemia in normal aging in healthy men. Diabetes Care 20(2), 135-141 (1997).
106. Adler GK, Bonyhay I, Failing H, Waring E, Dotson S, Freeman R. Antecedent hypoglycemia impairs autonomic cardiovascular function. Diabetes 58(2), 360-366 (2009).
107. Herlein JA, Morgan DA, Phillips BG, Haynes WG, Sivitz WI. Antecedent hypoglycemia, catecholamine depletion, and subsequent sympathetic neural responses. Endocrinology 147(6), 2781-2788 (2006).
108. Bao S, Briscoe VJ, Tate DB, Davis SN. Effects of differing antecedent increases of plasma cortisol on counter-regulatory responses during subsequent exercise in Type 1 diabetes. Diabetes 58(9), 2100-2108 (2009).
109. Davis SN, Shavers C, Costa F, Mosqueda- Garcia R. Role of cortisol in the pathogenesis of deficient counterregulation after antecedent hypoglycemia in normal humans. J. Clin. Invest. 98(3), 680-691 (1996).
110. McGregor VP, Banarer S, Cryer PE. Elevated endogenous cortisol reduces autonomic neuroendocrine and symptom responses to subsequent hypoglycemia. Am. J. Physiol. Endocrinol. Metab. 282(4), E770-E777 (2002).
111. Cryer PE. Exercise-related hypoglycemia-associated autonomic failure in diabetes. Diabetes 58(9), 1951-1952 (2009).
112. Raju B, McGregor VP, Cryer PE. Cortisol elevations camparable to those that occur during hypoglycemia do not cause hypoglycemia-associated autonomic failure. Diabetes 52(8), 2083-2089 (2003).
113. Goldberg PA, Weiss R, McCrimmon RJ, Hintz EV, Dziura JD, Sherwin RS. Antecedent hypercortisolemia is not primarily responsible for generating hypoglycemia-associated autonomic failure. Diabetes 55(4), 1121-1126 (2006).
114. Galassetti P, Tate D, Neill RA, Morrey S, Davis SN. Effect of gender on counter-regulatory responses to euglycemic exercise in Type 1 diabetes. J. Clin. Endocrinol. Metab. 87(11), 5144-5150 (2002).
115. Galassetti P, Tate D, Neill RA, Morrey S, Wasserman DH, Davis SN. Effect of sex on counter-regulatory responses to exercise after antecedent hypoglycemia in Type 1 diabetes. Am. J. Physiol. Endocrinol. Metab. 287(1), E16-E24 (2004).
116. Galassetti P, Neill AR, Tate D, Ertl AC, Wasserman DH, Davis SN. Sexual dimorphism in counter-regulatory responses to hypoglycemia after antecedent exercise. J. Clin. Endocrinol. Metab. 86(8), 3516-3524 (2001).
117. Davis SN, Fowler S, Costa F. Hypoglycemic counter-regulatory responses differ between men and women with Type 1 diabetes. Diabetes 49(1), 65-72 (2000).
118. Preparticipation health screening and risk stratification. In: ACSM's Guidelines for Exercise Testing and Prescription (8th Edition). Thompson WR (Ed.). Wolters Kluwer Health/Lippincott Williams & Wilkins, PA, USA, 18-39 (2010).
119. American Diabetes Association. Diabetes mellitus and exercise. Diabetes Care 25(Suppl. 1), S64-S68 (2002).
120. Bax JJ, Young LH, Frye RL, Bonow RO, Steinberg HO, Barrett EJ. Screening for coronary artery disease in patients with diabetes. Diabetes Care 30(10), 2729-2736 (2007).
121. American Diabetes Association. Standards of medical care in diabetes-2010. Diabetes Care 33(Suppl. 1), S11-S61 (2010).
122. American Diabetes Association. Standards of medical care in diabetes-2006. Diabetes Care 29(Suppl. 1), S4-S42 (2006).
123. Eriksen L, Dahl-Petersen I, Haugaard SB, Dela F. Comparison of the effect of multiple short-duration with single long-duration exercise sessions on glucose homeostasis in Type 2 diabetes mellitus. Diabetologia 50(11), 2245-2253 (2007).
124. Ivy JL. Role of exercise training in the prevention and treatment of insulin resistance and non-insulin-dependent diabetes mellitus. Sports Med. 24(5), 321-336 (1997).
125. Sigal RJ, Kenny GP, Boule NG et al. Effects of aerobic training, resistance training, or both on glycemic control in Type 2 diabetes, a randomized trial. Ann. Intern. Med. 147(6), 357-369 (2007).
126. American College of Sports Medicine. American College of Sports Medicine Position Stand: exercise and physical activity for older adults. Med. Sci. Sports Exerc. 30(6), 992-1008 (1998).
127. Klonoff DC. Continuous glucose monitoring: roadmap for 21st Century diabetes therapy. Diabetes Care 28(5), 1231-1239 (2005).
128. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Sustained benefit of continuous glucose monitoring on A1C, glucose profiles, and hypoglycemia in adults with Type 1 diabetes. Diabetes Care 32(11), 2047-2049 (2009).
129. Leinung M, Thompson S, Nardacci E. Benefits of continuous glucose monitor use in clinical practice. Endocr. Pract. 16(3), 371-375 (2010).
130. Kirk SE. Hypoglycemia in athletes with diabetes. Clin. Sports Med. 28(3), 455-468 (2009).
131. Thow JC, Johnson AB, Antsiferov M, Home PD. Exercise augments the absorption of isophane (NPH) insulin. Diabet. Med. 6(4), 342-345 (1989).
132. Peter R, Luzio SD, Dunseath G et al. Effects of exercise on the absorption of insulin glargine in patients with Type 1 diabetes. Diabetes Care 28(3), 560-565 (2005).
133. Arutchelvam V, Heise T, Dellweg S, Elbroend B, Minns I, Home PD. Plasma glucose and hypoglycaemia following exercise in people with Type 1 diabetes: a comparison of three basal insulins. Diabet. Med. 26(10), 1027-1032 (2009).
134. Admon G, Weinstein Y, Falk B. Exercise with and without an insulin pump among children and adolescents with Type 1 diabetes mellitus. Pediatrics 116(3), e348-e355 (2005).
135. Tuominen JA, Karonen SL, Melamies L, Bolli G, Koivisto VA. Exercise-induced hypoglycemia in IDDM patients treated with a short-acting insulin analogue. Diabetologia 38(1), 106-111 (1995).
136. Koivisto VA, Felig P. Effects of leg exercise on insulin absorption in diabetic patients. N. Engl. J. Med. 298(2), 79-83 (1978).
137. Dubé M-C, Weisnagel SJ, Prud'homme D, Lavoie C. Exercise and newer insulins: how much glucose supplement to avoid hypoglycemia? Med. Sci. Sports Exerc. 37(8), 1276-1282 (2005).
138. Francescato MP, Geat M, Fusi S, Stupar G, Noacco C, Cattin L. Carbohydrate requirement and insulin concentration during moderate exercise in Type 1 diabetic patients. Metabolism 53(9), 1126-1130 (2004).
139. Grimm JJ, Ybarra J, Berné C, Muchnick S, Golay A. A new table for prevention of hypoglycaemia during physical activity in Type 1 diabetic patients. Diabetes Metab. 30(5), 465-470 (2004).
140. Wasserman DH, Zinman B. Exercise in individuals with IDDM. Diabetes Care 17(8), 924-937 (1994).
141. Nathan DM, Madnek SF, Delahanty L. Programming pre-exercise snacks to prevent postexercise hypoglycemia in intensively treated insulin-dependent diabetics. Ann. Intern. Med. 102(4), 483-486 (1985).
142. Ruegemer JJ, Squires RW, Marsh HM et al. Differences between prebreakfast and late afternoon glycemic responses to exercise in IDDM patients. Diabetes Care 13(2), 104-110 (1990).
143. Schiffrin A, Parikh S, Marliss EB, Desrosiers MM. Metabolic response to fasting exercise in adolescent insulin-dependent diabetic subjects treated with continuous subcutaneous insulin infusion and intensive conventional therapy. Diabetes Care 7(3), 255-260 (1984).
144. McMahon SK, Ferreira LD, Ratnam N et al. Glucose requirements to maintain euglycemia after moderate-intensity afternoon exercise in adolescents with Type 1 diabetes are increased in a biphasic manner. J. Clin. Endocrinol. Metab. 92(3), 963-968 (2007).
145. Tsalikian E, Mauras N, Beck RW et al.; Diabetes Research in Children Network DirecNet Study Group. Impact of exercise on overnight glycemic control in children with Type 1 diabetes mellitus. J. Pediatr. 147(4), 528-534 (2005).
146. Sigal RJ, Fisher S, Halter JB, Vranic M, Marliss EB. The roles of catecholamines in glucoregulation in intense exercise as defined by the islet cell clamp technique. Diabetes 45(2), 148-156 (1996).
147. Kreisman SH, Halter JB, Vranic M, Marliss EB. Combined infusion of epinephrine and norepinephrine during moderate exercise reproduces the glucoregulatory response of intense exercise. Diabetes 52(6), 1347-1354 (2003).
148. Guelfi KJ, Jones TW, Fournier PA. The decline in blood glucose levels is less with intermittent high-intensity compared with moderate exercise in individuals with Type 1 diabetes. Diabetes Care 28(6), 1289-1294 (2005).
149. Bussau VA, Ferreira LD, Jones TW, Fournier PA. A 10-s sprint performed prior to moderate-intensity exercise prevents early post-exercise fall in glycaemia in individuals with Type 1 diabetes. Diabetologia 50(9), 1815-1818 (2007).
150. Bussau VA, Ferreira LD, Jones TW, Fournier PA. The 10-s maximal sprint: a novel approach to counter an exercise-mediated fall in glycemia in individuals with Type 1 diabetes. Diabetes Care 29(3), 601-606 (2006).
151. Marliss EB, Vranic M. Intense exercise has unique effects on both insulin release and its roles in glucoregulation: implications for diabetes. Diabetes 51(Suppl.1), S271-S283 (2002).
152. Herz M, Profozic V, Arora V et al. Effects of a fixed mixture of 25% insulin lispro and 75% NPL on plasma glucose during and after moderate physical exercise in patients with Type 2 diabetes. Curr. Med. Res. Opin 18(4), 188-193 (2002).